EDT.TO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 14:56):

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America...

Stats
Today's Volume	12 068.00
Average Volume	103 533
Market Cap	122.57M
EPS	$0 ( 2024-03-25 )
Next earnings date	( $0 ) 2024-05-09
Last Dividend	$0.120 ( 2011-12-19 )
Next Dividend	$0 ( N/A )
P/E	-7.33
ATR14	$0 (0.00%)

Spectral Medical Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Spectral Medical Inc Financials

Annual	2023
Revenue:	$1.60M
Gross Profit:	$-4.81M (-301.06 %)
EPS:	$-0.0562

Q4	2023
Revenue:	$365 000
Gross Profit:	$-1.02M (-280.27 %)
EPS:	$-0.0235

Q3	2023
Revenue:	$397 000
Gross Profit:	$92 000.00 (23.17 %)
EPS:	$-0.0122

Q2	2023
Revenue:	$306 000
Gross Profit:	$25 000.00 (8.17 %)
EPS:	$-0.0141

Financial Reports:

No articles found.

Spectral Medical Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Spectral Medical Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.120	2011-12-19
Last Dividend	$0.120	2011-12-19
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.120	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-24)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for TSX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
XCH.TO	Dividend Junior	2023-06-26	Semi-Annually	15	0.80%
PEY.TO	Dividend King	2023-09-28	Monthly	22	3.86%
ERF.TO	Dividend King	2023-08-30	Quarterly	34	1.21%
ZMID.TO	Dividend Junior	2023-06-28	Quarterly	5	0.72%
TECK-B.TO	Dividend Knight	2023-09-14	Quarterly	30	1.11%
IQD.TO	Dividend Junior	2023-09-22	Quarterly	8	1.50%
CJR-B.TO	Dividend Knight	2023-07-28	Quarterly	22	2.76%
XHB.TO	Dividend Knight	2023-08-25	Monthly	15	2.21%
PSB.TO	Dividend King	2023-08-29	Monthly	13	1.71%
FIE.TO	Dividend King	2023-07-25	Monthly	15	3.68%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-9.76	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-2.99	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	1.629	1.500	10.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.403	0.800	-2.99	-2.39	[1 - 3]
quickRatioTTM	0.306	0.800	-2.90	-2.32	[0.8 - 2.5]
cashRatioTTM	0.288	1.500	9.51	10.00	[0.2 - 2]
debtRatioTTM	1.547	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	-8.77	1.000	-4.36	-4.36	[3 - 30]
operatingCashFlowPerShareTTM	-0.0385	2.00	-0.0128	-0.0257	[0 - 30]
freeCashFlowPerShareTTM	-0.0391	2.00	-0.0196	-0.0391	[0 - 20]
debtEquityRatioTTM	-0.487	-1.500	-1.948	2.92	[0 - 2.5]
grossProfitMarginTTM	-0.321	1.000	-8.68	-8.68	[0.2 - 0.8]
operatingProfitMarginTTM	-7.32	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-1.330	1.000	-8.50	-8.50	[0.2 - 2]
assetTurnoverTTM	0.307	0.800	-1.289	-1.031	[0.5 - 2]
Total Score				-3.28

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-7.86	1.000	-0.895	0	[1 - 100]
returnOnEquityTTM	1.629	2.50	10.00	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0391	2.00	-0.0130	-0.0391	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.0385	2.00	-0.0128	-0.0257	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0549	1.500	-2.97	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-6.71	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-0.540

Spectral Medical Inc

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.